Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an announcement.
ResMed Inc has reported changes in beneficial ownership involving its director, Carol Burt. The transaction involved the acquisition of 1,073 shares of ResMed common stock, with the shares awarded as Restricted Stock Units that will vest in full by November 2026 or at the next annual meeting of stockholders. This transaction highlights the company’s ongoing practices in stock-based compensation, which can impact shareholder value and executive incentives.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$42.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc operates in the healthcare industry, focusing on the development and manufacturing of equipment related to sleep disorders, particularly sleep apnea. The company is known for its innovative solutions in respiratory care, including devices and cloud-connected software applications that improve patient outcomes and reduce healthcare costs.
Average Trading Volume: 1,214,271
Technical Sentiment Signal: Buy
Current Market Cap: A$56.69B
For a thorough assessment of RMD stock, go to TipRanks’ Stock Analysis page.